MELBOURNE researchers are a step closer to growing transplantable tissue to patch up heart defects after turning human skin cells into “beating heart” tissue that can connect to the circulation system.
The major breakthrough by the O’Brien Institute in preclinical models could eventually aid heart-attack victims and is also tipped to reduce the number of animals used in testing new drugs.
O’Brien’s cardiac regeneration group leader, Dr Shiang Lim, said while laboratories around the world were making heart cells from stem cells, his team had advanced the research by successfully connecting the human heart tissue to the host’s blood circulation.
“People have managed to create 3D heart tissue in the laboratory, but the size and thickness is limited by the lack of blood vessels,” Dr Lim said.
“We’re letting the body do its natural work.
“The blood vessels aren’t just sitting there, they’re functional and supplying blood to the heart tissue.”
Researchers first genetically reprogrammed human skin cells to become stem cells, which they further changed into heart cells using chemical and electrical stimulation.
Using a 3D chamber pioneered by the Melbourne regenerative surgery institute, they implanted these human heart cells into an animal model, connecting it to its blood vessel.
The findings, published in the journal, Stem Cells Translational Medicine, showed that four weeks after implantation, the implanted human heart cells had survived, engrafted into the surrounding tissue and were beating.
Dr Lim said the first application for their beating heart tissue would be for drug testing to help reduce and complement animal experimentation, reducing the time and cost of getting a medication on to market.
“We know a lot of drugs discovered and tested in animals work great, but when it’s translated into humans doesn’t work because of the biological differences,” he said.
“We can test on this engineered human heart tissue first before moving into clinical trials.”
Go deeper with Bing News on:
- Recombinetics Announces Collaboration with...on February 27, 2020 at 12:00 am
St. Paul, MN, February 27, 2020 --(PR.com)-- Recombinetics (RCI) today announced a collaborative research project with University of Texas Southwestern (UTSW) to identify key factors that improve the ...
- On the Road to 3-D Printed Organson February 26, 2020 at 2:35 pm
But many researchers have moved beyond printing with plastics and metals—printing with cells that then form living human tissues. No one has printed fully functional, transplantable human organs just ...
- MTF Biologics Awards $1.8 Million in 2019 Extramural Research Grantson February 26, 2020 at 8:29 am
We provide unmatched service, resources, and expertise to donors and their loved ones who give the gift of life, people who depend on tissue and organ transplants, healthcare providers, and clinicians ...
- 2YH: Birth tissue donation now available to pregnant moms in Alaskaon February 25, 2020 at 11:37 am
Dr. Brittany Strickland and Meghan Barnett Sonnabend have something in common. They're both moms, but they're also birth tissue donors. "It was just kind of always an interest and then it never really ...
- Donor Profile, Tissue Evaluation and Comparison of Voluntary and Motivated Corneal Donation in Nepal Eye Bank.on February 18, 2020 at 11:30 am
76.2% of total tissues were of optical quality. Utilization rate of transplantable tissues was 97%. Tissues from motivated donors were significantly “younger” (p=0.0001), had better endothelial count ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Engineered human heart tissue
- BIOLIFE4D CSO Dr. Ravi Birla Publishes Paper in Prestigious APL Bioengineering Scholarly Journalon February 27, 2020 at 5:30 am
Birla co-published paper with Stuart K. Williams, a renowned industry figure, to highlight 3D bioprinting’s impact on cardiac failure treatment ...
- Foldax Tria LifePolymer Heart Valve Technology Honored with Best Innovation Award at 2020 Cardiovascular Research Technologies Meetingon February 26, 2020 at 6:00 am
By utilizing computer engineering and robotic manufacturing ... and providing a quality of life similar to natural human valves. Tria heart valves are revolutionizing the industry as the first and ...
- B38-CAP is a bacteria-derived ACE2-like enzyme that suppresses hypertension and cardiac dysfunctionon February 26, 2020 at 2:54 am
Our data identify the bacterial B38-CAP as an ACE2-like carboxypeptidase, indicating that evolution has shaped a bacterial carboxypeptidase to a human ACE2-like enzyme. Bacterial engineering could be ...
- Novoheart Named 2020 Venture 50 Company, Ranked Among Year’s Top Performing Stocks in Life Scienceson February 20, 2020 at 6:30 am
Novoheart Among Top 10 TSX-V Performers in Clean Technology & Life Sciences SectorRanking based on share price increase, trading volume and ...
- Engineering light-controllable CAR T cells for cancer immunotherapyon February 19, 2020 at 12:47 pm
This on-target off-tumor toxicity is especially lethal when the infused CAR T cells are activated by the normal cells expressing low levels of target antigens in the heart, liver, or lung ... a ...